Canada · Delayed Price · Currency is CAD Quinsam Capital Earnings Call Transcripts
Fiscal Year 2026
-
Second quarter delivered modest profits and continued share buybacks, with a positive Q3 outlook driven by anticipated listings and portfolio gains. Key holdings like Peninsula Capital and California Nanotechnologies are positioned for growth.
-
NAV rose by over CAD 1 million in Q1, driven by strong mining investments and a profitable exit from oil and gas. Key upcoming catalysts include Peninsula's listing and potential commercial contracts in the nuclear sector, with continued positive NAV trends.
Fiscal Year 2025
-
Q4 closed with a small profit and NAV at CAD 0.10, with further NAV growth expected in Q1 due to strong public equity performance. Key investments in Deep Sea Minerals, Nevada Organic Phosphate, and Peninsula contributed to gains, while new opportunities like Bond Intelligence are being explored.
-
Q3 saw a small profit with limited activity, but Q4 could bring significant NAV growth if key private investments complete public listings. Notable developments include clinical progress at Asynaptic and a conservative write-down of Newlox Gold, with market volatility remaining a factor.
-
Q2 saw a modest loss due to California Nanotechnologies' share price drop, but gains from Music Royalties' public listing and several upcoming IPOs are expected to boost NAV. The portfolio is now diversified across real estate, mining, royalties, and tech.
-
A quiet first quarter saw minimal trading and a small gain from share price movements. Several private investments are preparing to list soon, which is expected to increase portfolio liquidity in the next quarter.
Fiscal Year 2024
-
Profitable Q3 driven by a tripling in California Nanotechnologies' value and positive contributions from Givex. Over CAD 1 million added to liquid assets, with cost reductions exceeding CAD 100,000. Optimism remains for increased liquidity and NAV growth, despite some sector headwinds.